Vicarious Surgical (RBOT) Shares Outstanding (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Shares Outstanding (Entity) of $7.1 million for Q4 2025, up 20.24% year-over-year from $5.9 million in Q4 2024, and up 19.42% quarter-over-quarter from $6.0 million in Q3 2025.
Vicarious Surgical (RBOT) Shares Outstanding (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Shares Outstanding (Entity) for 6 consecutive years, with $7.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 20.24% year-over-year to $7.1 million; the TTM figure through Dec 2025 stood at $7.1 million (up 20.24% YoY), while the FY2025 annual figure was $7.1 million, up 20.24% from the prior year.
- Shares Outstanding (Entity) improved to $7.1 million in Q4 2025 per RBOT's latest filing, from $6.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $7.1 million in Q4 2025 and bottomed at $1.1 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $4.4 million across 5 years, with a median of $4.6 million in 2023.
- On a YoY basis, Shares Outstanding (Entity) climbed as much as 300.0% in 2021 and fell as far as 24.4% in 2021.
- Vicarious Surgical's Shares Outstanding (Entity) stood at $1.3 million in 2021, then soared by 217.41% to $4.2 million in 2022, then grew by 15.99% to $4.9 million in 2023, then rose by 21.63% to $5.9 million in 2024, then advanced by 20.24% to $7.1 million in 2025.
- Business Quant data shows RBOT's Shares Outstanding (Entity) at $7.1 million in Q4 2025, $6.0 million in Q3 2025, and $5.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | 5.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.95 Mn |
| Sep 30, 2025 | 5.95 Mn |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 5.92 Mn |
| Dec 31, 2024 | 5.89 Mn |
| Sep 30, 2024 | 5.90 Mn |
| Jun 30, 2024 | 5.87 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 4.87 Mn |
| Sep 30, 2023 | 5.17 Mn |
| Jun 30, 2023 | 4.23 Mn |
| Mar 31, 2023 | 4.20 Mn |
| Dec 31, 2022 | 4.06 Mn |
| Sep 30, 2022 | 4.07 Mn |
| Jun 30, 2022 | 4.04 Mn |
| Mar 31, 2022 | 4.25 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.31 Mn |
| Jun 30, 2021 | 1.15 Mn |
| Mar 31, 2021 | 1.15 Mn |